Atlas Trials

Observational Study for the Evaluation of Immune-mediated Endocrinological Adverse Events in Patients With Hematological Malignancies and Subjected to Treatment With Immune-checkpoint Inhibitors

Clinical trial NCT06851702 · RECRUITING

Trial details

NCT number
NCT06851702
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status
RECRUITING
Study type
OBSERVATIONAL
Hematological Malignancies
Start date
2025-06-01
Primary completion
2025-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.